title: Serum-free cryopreservation of human amniotic epithelial cells before and after isolation from their natural scaffold.
abstract: Amniotic epithelial cells are a promising source for stem cell-based therapy through their potential capacity to differentiate into the cell lineages of all three germ layers. Long-term preservation is necessary to have a ready-to-use source of stem cells, when required. Reduced differentiation capability, decrease of viability and use of fetal bovine serum (FBS) are three drawbacks of clinical application of cryopreserved stem cells. In this study, we used human amniotic fluid instead of animal serum, and evaluated viability and multipotency of amniotic epithelial cells after cryopreservation in suspension and compared with those cryopreserved on their natural scaffold (in situ cryopreservation). There was no significant difference in viability of the cells cryopreserved in amniotic fluid and FBS. Also, the same results were achieved for expression of pluripotency marker OCT-4 when FBS was replaced by amniotic fluid in the samples with the same cryoprotectant. The cells cryopreserved in presence of scaffold had a higher level of viability compared to the cells cryopreserved in suspension. Although, the number of the cells expressed OCT-4 significantly decreased within cryopreservation in suspension, no decrease in expression of OCT-4 was observed when the cells cryopreserved with their natural scaffold. Upon culturing of post-thawed cells in specific lineage differentiating mediums, the markers of neuronal, hepatic, cardiomyocytic and pancreatic were found in differentiated cells. These results show that replacement of FBS by amniotic fluid and in situ cryopreservation of amniotic epithelial cells is an effective approach to overcome limitations related to long-term preservation including differentiation during cryopreservation and decrease of viability.
authors.affiliation: Nanomedicine and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. niknejad@sbmu.ac.ir
authors.forename: Hassan
authors.initials: H
authors.lastname: Niknejad
authors.forename: Tina
authors.initials: T
authors.lastname: Deihim
authors.forename: Habibollah
authors.initials: H
authors.lastname: Peirovi
authors.forename: Hassan
authors.initials: H
authors.lastname: Abolghasemi
mesh_terms: D000653:Amniotic Fluid / Q000166:cytology; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000494:pharmacology*; D003470:Culture Media / Q000494:pharmacology*; D004121:Dimethyl Sulfoxide / Q000494:pharmacology*; D004847:Epithelial Cells; D005990:Glycerol / Q000494:pharmacology; D006801:Humans; D050814:Octamer Transcription Factor-3 / Q000378:metabolism; D044967:Serum
chemical_list: D003451:Cryoprotective Agents; D003470:Culture Media; D050814:Octamer Transcription Factor-3; C494173:POU5F1 protein, human; D005990:Glycerol; D004121:Dimethyl Sulfoxide